Killer cell immunoglobulin-like receptor 3DS1
| GO Term | Evidence Code | Reference |
|---|---|---|
| immune response-regulating signaling pathway |
|
|
| immune response | ||
| natural killer cell activation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| MHC class I receptor activity |
| Pathway Name | Organism |
|---|---|
| DAP12 interactions | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:12365 | malaria | |
| DOID:0080600 | COVID-19 | |
| DOID:2957 | pulmonary tuberculosis | |
| DOID:635 | acquired immunodeficiency syndrome | |
| DOID:0080827 | human cytomegalovirus infection | |
| DOID:5082 | liver cirrhosis | |
| DOID:12206 | dengue hemorrhagic fever | |
| DOID:684 | hepatocellular carcinoma | |
| DOID:1883 | hepatitis C | |
| DOID:2043 | hepatitis B |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026